Magenta Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Genomic Medicines & Rare Disease Conference

Rhea-AI Summary

Magenta Therapeutics (NASDAQ: MGTA) has announced that President and CEO Jason Gardner will speak at the Guggenheim Healthcare Talks 2021 Genomic Medicines & Rare Disease Conference on April 1, 2021, at 1:00 p.m. ET. The discussion, titled Key Advances in Solid Organ and Stem Cell Transplants - Expanding the Market and Moving Away from Lifelong Immunosuppression, will focus on revolutionary developments in stem cell transplants. A live webcast will be available on the company's website, with a replay accessible for 90 days after the event.

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced that Jason Gardner, D.Phil., President and Chief Executive Officer, is scheduled to participate in a panel discussion at the Guggenheim Healthcare Talks 2021 Genomic Medicines & Rare Disease Conference, being held virtually, on Thursday, April 1^st, 2021. The panel discussion, Key Advances in Solid Organ and Stem Cell Transplants - Expanding the Market and Moving Away from Lifelong Immunosuppression, will take place at 1:00 p.m. ET.

A live webcast of the panel discussion can be accessed on the Magenta Therapeutics website at https://investor.magentatx.com/events-and-presentations. The webcast replay will be available for 90 days following the event.

About Magenta Therapeutics

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.

Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com.

Follow Magenta on Twitter: @magentatx.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210325005257/en/

FAQ

What is the date of the Magenta Therapeutics panel discussion at the Guggenheim Healthcare Talks?

The panel discussion is scheduled for April 1, 2021.

Who is representing Magenta Therapeutics at the Guggenheim Healthcare Talks?

Jason Gardner, D.Phil., President and CEO of Magenta Therapeutics, will be representing the company.

What is the topic of the panel discussion featuring Magenta Therapeutics?

The topic is Key Advances in Solid Organ and Stem Cell Transplants - Expanding the Market and Moving Away from Lifelong Immunosuppression.

Where can I watch the Magenta Therapeutics panel discussion?

The panel discussion can be accessed via a live webcast on the Magenta Therapeutics website.

How long will the webcast replay be available after the event?

The webcast replay will be available for 90 days following the event.